CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice
RationaleIncreased IL-8 levels and neutrophil accumulation in the airways are common features found in patients affected by pulmonary diseases such as Asthma, Idiopathic Pulmonary Fibrosis, Influenza-A infection and COPD. Chronic neutrophilic inflammation is usually corticosteroid insensitive and ma...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.566953/full |
id |
doaj-0969a009515a4dc4bbe51c215c940f9d |
---|---|
record_format |
Article |
spelling |
doaj-0969a009515a4dc4bbe51c215c940f9d2020-11-25T01:19:28ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-10-011110.3389/fimmu.2020.566953566953CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in MiceMatheus Silverio Mattos0Maximiliano Ruben Ferrero1Lucas Kraemer2Gabriel Augusto Oliveira Lopes3Diego Carlos Reis4Geovanni Dantas Cassali5Fabricio Marcus Silva Oliveira6Laura Brandolini7Marcello Allegretti8Cristiana Couto Garcia9Marco Aurélio Martins10Mauro Martins Teixeira11Remo Castro Russo12Remo Castro Russo13Laboratory of Comparative Pathology, Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilLaboratory of Inflammation, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, BrazilLaboratory of Comparative Pathology, Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilLaboratory of Comparative Pathology, Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilLaboratory of Comparative Pathology, Department of General Pathology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilLaboratory of Comparative Pathology, Department of General Pathology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilLaboratory of Comparative Pathology, Department of General Pathology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilR&D Department, Dompé Farmaceutici S.p.a., L’Aquila, ItalyR&D Department, Dompé Farmaceutici S.p.a., L’Aquila, ItalyLaboratory of Respiratory Virus and Measles, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, BrazilLaboratory of Inflammation, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, BrazilLaboratory of Immunopharmacology, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilLaboratory of Comparative Pathology, Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilLaboratory of Immunopharmacology, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilRationaleIncreased IL-8 levels and neutrophil accumulation in the airways are common features found in patients affected by pulmonary diseases such as Asthma, Idiopathic Pulmonary Fibrosis, Influenza-A infection and COPD. Chronic neutrophilic inflammation is usually corticosteroid insensitive and may be relevant in the progression of those diseases.ObjectiveTo explore the role of Ladarixin, a dual CXCR1/2 antagonist, in several mouse models of airway inflammation with a significant neutrophilic component.FindingsLadarixin was able to reduce the acute and chronic neutrophilic influx, also attenuating the Th2 eosinophil-dominated airway inflammation, tissue remodeling and airway hyperresponsiveness. Correspondingly, Ladarixin decreased bleomycin-induced neutrophilic inflammation and collagen deposition, as well as attenuated the corticosteroid resistant Th17 neutrophil-dominated airway inflammation and hyperresponsiveness, restoring corticosteroid sensitivity. Finally, Ladarixin reduced neutrophilic airway inflammation during cigarette smoke-induced corticosteroid resistant exacerbation of Influenza-A infection, improving lung function and mice survival.ConclusionCXCR1/2 antagonist Ladarixin offers a new strategy for therapeutic treatment of acute and chronic neutrophilic airway inflammation, even in the context of corticosteroid-insensitivity.https://www.frontiersin.org/article/10.3389/fimmu.2020.566953/fullneutrophils (PMNs)asthmafibrosischronic obstructive pulmonary diseaseinfluenza A (H1N1) |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Matheus Silverio Mattos Maximiliano Ruben Ferrero Lucas Kraemer Gabriel Augusto Oliveira Lopes Diego Carlos Reis Geovanni Dantas Cassali Fabricio Marcus Silva Oliveira Laura Brandolini Marcello Allegretti Cristiana Couto Garcia Marco Aurélio Martins Mauro Martins Teixeira Remo Castro Russo Remo Castro Russo |
spellingShingle |
Matheus Silverio Mattos Maximiliano Ruben Ferrero Lucas Kraemer Gabriel Augusto Oliveira Lopes Diego Carlos Reis Geovanni Dantas Cassali Fabricio Marcus Silva Oliveira Laura Brandolini Marcello Allegretti Cristiana Couto Garcia Marco Aurélio Martins Mauro Martins Teixeira Remo Castro Russo Remo Castro Russo CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice Frontiers in Immunology neutrophils (PMNs) asthma fibrosis chronic obstructive pulmonary disease influenza A (H1N1) |
author_facet |
Matheus Silverio Mattos Maximiliano Ruben Ferrero Lucas Kraemer Gabriel Augusto Oliveira Lopes Diego Carlos Reis Geovanni Dantas Cassali Fabricio Marcus Silva Oliveira Laura Brandolini Marcello Allegretti Cristiana Couto Garcia Marco Aurélio Martins Mauro Martins Teixeira Remo Castro Russo Remo Castro Russo |
author_sort |
Matheus Silverio Mattos |
title |
CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice |
title_short |
CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice |
title_full |
CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice |
title_fullStr |
CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice |
title_full_unstemmed |
CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice |
title_sort |
cxcr1 and cxcr2 inhibition by ladarixin improves neutrophil-dependent airway inflammation in mice |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2020-10-01 |
description |
RationaleIncreased IL-8 levels and neutrophil accumulation in the airways are common features found in patients affected by pulmonary diseases such as Asthma, Idiopathic Pulmonary Fibrosis, Influenza-A infection and COPD. Chronic neutrophilic inflammation is usually corticosteroid insensitive and may be relevant in the progression of those diseases.ObjectiveTo explore the role of Ladarixin, a dual CXCR1/2 antagonist, in several mouse models of airway inflammation with a significant neutrophilic component.FindingsLadarixin was able to reduce the acute and chronic neutrophilic influx, also attenuating the Th2 eosinophil-dominated airway inflammation, tissue remodeling and airway hyperresponsiveness. Correspondingly, Ladarixin decreased bleomycin-induced neutrophilic inflammation and collagen deposition, as well as attenuated the corticosteroid resistant Th17 neutrophil-dominated airway inflammation and hyperresponsiveness, restoring corticosteroid sensitivity. Finally, Ladarixin reduced neutrophilic airway inflammation during cigarette smoke-induced corticosteroid resistant exacerbation of Influenza-A infection, improving lung function and mice survival.ConclusionCXCR1/2 antagonist Ladarixin offers a new strategy for therapeutic treatment of acute and chronic neutrophilic airway inflammation, even in the context of corticosteroid-insensitivity. |
topic |
neutrophils (PMNs) asthma fibrosis chronic obstructive pulmonary disease influenza A (H1N1) |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2020.566953/full |
work_keys_str_mv |
AT matheussilveriomattos cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT maximilianorubenferrero cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT lucaskraemer cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT gabrielaugustooliveiralopes cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT diegocarlosreis cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT geovannidantascassali cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT fabriciomarcussilvaoliveira cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT laurabrandolini cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT marcelloallegretti cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT cristianacoutogarcia cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT marcoaureliomartins cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT mauromartinsteixeira cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT remocastrorusso cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice AT remocastrorusso cxcr1andcxcr2inhibitionbyladarixinimprovesneutrophildependentairwayinflammationinmice |
_version_ |
1725138075909095424 |